Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 1/20 | 0.60 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.57 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.57 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.57 |
| ▸ | ITGAL | P20701 | 2/20 | 0.57 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | NLN | Q9BYT8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29971719 | 1.00 | REN (0.60) | RENAGTR2ITGB2ICAM1ITGAL | |
| SCHEMBL27826956 | 0.95 | AGTR2 (0.60) | RENAGTR2ITGB2ICAM1ITGAL | |
| SCHEMBL30184773 | 0.95 | AGTR2 (0.60) | RENAGTR2ITGB2ICAM1ITGAL | |
| SCHEMBL21828676 | 0.91 | CYP3A4 (0.53) | RENITGB2ICAM1ITGALMME | |
| SCHEMBL29971925 | 0.91 | CYP3A4 (0.53) | RENITGB2ICAM1ITGALMME | |
| SCHEMBL21828671 | 0.90 | CYP3A4 (0.68) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| Hydrochloric Acid SCHEMBL20335511 | 0.90 | CYP3A4 (0.52) | RENITGB2ICAM1ITGALMME | |
| SCHEMBL13563453 | 0.89 | REN (0.72) | REN | |
| Bromide SCHEMBL27422846 | 0.88 | REN (0.58) | RENMMEECE1LTA4H | |
| SCHEMBL29380221 | 0.88 | CYP3A4 (0.65) | RENITGB2ICAM1ITGALCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117778510-A | Preparation method of caper bitter peptide | 昆明理工大学 | 2024-03-29 | — | — | CN | claimed |
| CN-119874816-A | Tartary buckwheat protein source hypolipidemic peptide and application thereof | 华南农业大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-113248624-B | SYNTAC polypeptides and uses thereof | 阿尔伯特爱因斯坦医学院 | 2025-02-07 | — | — | CN | disclosed |
| CN-113286609-B | Multimeric T cell modulating polypeptides and methods of use thereof | 库尔生物制药有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-118895313-A | Methods and compositions for genetically modifying and amplifying lymphocytes and modulating their activity | 埃克苏马生物技术公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-118852456-A | Multimeric T cell modulating polypeptides and methods of use thereof | CUE生物制药股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118453840-A | Methods for modulating immune responses | 库尔生物制药有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-111479921-B | Methods and compositions for genetically modifying and amplifying lymphocytes and modulating their activity | 埃克苏马生物技术公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-109843929-B | Proteolytically cleavable chimeric polypeptides and methods of use thereof | 加利福尼亚大学董事会 | 2024-07-05 | — | — | CN | disclosed |
| CN-117903282-A | T cell modulating multimeric polypeptides and methods of use thereof | 库尔生物制药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-116057181-A | Methods and compositions for modifying and delivering lymphocytes | 埃克苏马生物技术公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-108884460-B | Methods and compositions for modulation of lymphocyte transduction and expansion thereof | 埃克苏马生物技术公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-115724984-A | Autoimmune B cell eliminator molecules and uses thereof | 拓创生物科技(苏州)有限公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-114164134-B | Bifidobacterium longum subspecies longum with functions of preventing and relieving colitis symptoms and application thereof | 东北农业大学 | 2023-03-03 | — | — | CN | disclosed |
| CN-115702165-A | Humanized anti-complement factor Bb antibodies and uses thereof | 建新公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-115605494-A | Multimeric T cell modulating polypeptides and methods of use thereof | 株式会社LG化学（KR） | 2023-01-13 | — | — | CN | disclosed |
| CN-108610418-B | Anti-complement C1s antibodies and uses thereof | 美国比奥维拉迪维股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-115243713-A | Methods and compositions for delivering modified lymphocyte aggregates | 埃克苏马生物技术公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-114164134-A | Bifidobacterium longum subspecies longum with functions of preventing and relieving colitis symptoms and application thereof | 东北农业大学 | 2022-03-11 | — | — | CN | disclosed |
| CN-106573895-A | Novel 5-acylsulfanyl-histidine compounds as precursors for the corresponding 5-sulfanylhistidines and disulfides thereof | 特瑞海德公司 | 2017-04-19 | — | — | CN | disclosed |